Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salidroside to improve IVF pregnancy outcomes in older women with poor prognosis
ChiCTR2500104061Phase 4Recruiting
- Sponsor
- Second Hospital of Shandong University
- Start
- Jun 2025
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of salidroside in female infertility (2 arms), sponsored by Second Hospital of Shandong University. Primary endpoint: Continuous pregnancy rate. Started Jun 2025; status: recruiting.
02
Drugs
salidroside
03
Conditions
female infertility
Beyond the preview
Go deeper on ChiCTR2500104061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104061.